Press Release AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease 4 hours ago
Press Release AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline Aug 21
Press Release AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support Aug 18